Cite
HARVARD Citation
Lamberti, G. et al. (2020). Should we lose hope in adjuvant therapy for neuroendocrine tumors?—In response to: Adjuvant therapy following resection of gastroenteropancreatic neuroendocrine tumors provides no recurrence or survival benefit. Journal of surgical oncology. 122 (3), pp. 570-571. [Online].